NGF stimulates the differentiation and growth of cholinergic neurons of the basal forebrain and promotes the expression of the cholinergic neurochemical phenotype (Whittemore and Seiger, 1987; Hefti and Lapchak, 1993) . Considerable data derived from rodent models and recent studies in primates also suggest that NGF may be required for maintenance of their functional integrity and survival in adult brain (Thoenen et al., 1987; Araujo et al., 1993a,b; Hefti and Lapchak, 1993) . Thus, administration of exogenous NGF has been shown to stimulate the expression of presynaptic cholinergic markers in adult rat and monkey brain, enhancing choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities in several forebrain areas and increasing the V,,,,, for sodium-dependent high-affinity choline uptake (HACU) in septohippocampal and basocortical terminal fields (reviewed in Hefti and Lapchak, 1993; Rylett and Williams, 1994) . Similarly, in normal adult rats chronic intraventricular (i.c.v.) administration of NGF has been reported to increase the expression of NGF receptor and ChAT mRNA and induce hypertrophy of cholinergic neurons within the nucleus basalis, medial septum and diagonal band Fischer et al., I99 I) . In rats with experimental lesions that model the forebrain cholinergic deficits characteristic of Alzheimer's disease (AD), chronic infusions of NGF i.c.v. were found to prevent degenerative changes and loss of medial septum/diagonal band and nucleus basalis cholinergic neurons following limbria-fornix transections of the septohippocampal pathway and partial cortical infarction, respectively (Hefti, 1986; Williams et al., 1986; Gage et al., 1988; Hagg et al., 1988; Cuello et al., 1991) . Moreover, several groups have reported that behavioral deficits that result from lesions of the fimbria-fornix or nucleus basalis are reversed by administration of NGF (Will and Hefti, 1985; Mandel et al., 1989; Dekker et al., 1992) and in aged, behaviorally impaired rats, i.c.v. infusions of NGF were shown to enhance performance in a spatial memory task and reverse aged-related atrophy of basal forebrain cholinergic neurons (Fischer et al., 1987 (Fischer et al., , 1991 . Such findings have led to the proposal that administration of NGF might ameliorate deficits in forebrain cholinergic function and thereby play a therapeutic role in the treatment of memory loss and cognitive impairment associated with AD (Hefti and Weiner, 1986; Phelps et al., 1989; Hefti and Lapchak, 1993; .
An important question that remains to consider is whether the stimulation in cholinergic neurochemical activity demonstrated in response to NGF administration is reflected in enhanced synthesis or release of ACh, with a concomitant enhancement in cholinergic neurotransmission in brain. It was first shown in cultured rat septal neurons that incubation with NGF increased depolarization-evoked release of ACh (Takei et al., 1989) . Hefti and coworkers (Lapchak et al., 1992; Araujo et al., 1993) subsequently reported in adult rats that chronic i.c.v. infusions of recombinant human NGF rescued septohippocampal cholinergic neurons from degeneration induced by partial fimbrial transections and increased the capacity of surviving hippocampal cholinergic neurons to synthesize, store and release both endogenous and 3H-ACh. Moreover, Rylett et al. recently demonstrated in normal young adult and aged Fischer 344 rats that elevations in ChAT and HACU activity found in frontal cortex, hippocampus and striatum after chronic NGF treatment were accompanied by enhanced ACh synthetic capacity and depolarization-evoked release of both newly synthesized ?H-ACh and endogenous neurotransmitter, as measured in vitro. While these results are compatible with the view that chronic administration of NGF can facilitate transmitter-related functions in normal and dystrophic cholinergic neurons, it remains to be seen whether these effects translate into an enhancement in cholinergic synaptic activity, and therefore are likely to be of physiological significance. Up to now, it has been difficult to directly examine this issue owing to the lack of a suitable in vitro test system from which the requisite, quantifiable electrophysiological measures of cholinergic neurotransmission can be made. The amygdaloid complex in rat is known to receive a very dense projection of ACh-containing fibers from the basal forebrain (Woolf and Butcher, 1982; Mesulam et al., 1983; Carlsen et al., 1985; Hellendall et al., 1986) , and it is the nuclei contained within the basolateral amygdala (BLA) that provide the major targets of this cholinergic innervation (Carlsen et al., 1985; Carlsen and Heimer, 1986; Hellendall et al., 1986) . Immunohistochemical analyses for ChAT indicate that the cholinergic input to the BLA originates largely from neurons of the nucleus basalis and that the cholinergic input terminates predominantly on pyramidal-type neurons (Carlsen et al., 1985; Carlsen and Heimer, 1986; Woolf and Butcher, 1982) . We demonstrated by recording intracellularly from BLA pyramidal neurons in rat forebrain slices that the electrophysiological effects produced by cholinomimetics or stimulation of amygdalopetal cholinergic afferents were essentially indistinguishable from those elicited in cerebrocortical or hippocampal pyramidal neurons following muscarinic receptor activation (reviewed in Moises and Womble, 1995) . Thus, administration of cholinomimetics or release of endogenous ACh induced by stimulation of nucleus basalis increased postsynaptic excitability of BLA pyramidal neurons, producing a slow muscarinic depolarization and blockade of the calcium-activated potassium slow afterhyperpolarization (slow AHP) (Washburn and Moises, 1992a; Moises, 1992, 1993) . The fact that the normal synaptic relationship between cholinergic source neurons and their postsynaptic amygdaloid target cells is maintained in horizontal slice preparations of rat ventral forebrain suggested that the amygdalopetal projection from nucleus basalis to BLA might serve as a model test system for assessing changes in cholinergic neurotransmission in adult brain after treatment in vivo with NGE In the present study, we compared the ability of cholinergic pathway stimulation to elicit muscarinic responses in BLA pyramidal neurons in slices prepared from NGF-and vehicle-treated Fischer 344 rats to determine whether cholinergic neurotransmission is enhanced after chronic administration of the neurotrophic factor. The sensitivity of pyramidal neurons to bath application of cholinergic agonists was also compared between control and NGF-treated preparations to ascertain the presynaptic versus postsynaptic locus of any changes observed in cholinergic synaptic fidelity after NGF treatment.
Materials and Methods
Animals and care. Male Fischer 344 rats, 4 months of age, were obtained from the National Institutes on Aging colony at Harlan/SpragueDawley (Indianapolis, IN). Animals were housed in small groups in a temperature (22°C) controlled room with a daily photoperiod of 12 hr of light between 0600 and 1800 hr. Animals had free access to water and were fed ad libitum a standard laboratory diet.
NGF preparation and administration. Three weeks prior to electrophysiological study each animal was implanted with a cannula into the right lateral ventricle using a procedure modified from Williams et al. . Cannulae were placed under surgical anesthesia induced by intramuscular injection (4 ml/kg) of a mixture of ketamine (4 mg/ml), xylazine (Rompun, 1.3 mg/ml), and acepromzaine (0.25 mg/ ml). Alzet osmotic minipumps, model 2ML4 (Alza Corp., Palo Alto, CA), were attached to the cannulae and used to deliver sterile reninfree NGF (obtained from Bioproducts for Science, Indianapolis) or vehicle solution for three weeks. The concentration of pure NGF in a stock solution of PBS was determined by molar extinction (1.64 OD280/mg/ml), and aliquots of 1 mg/ml were stored at -70°C until use. The concentration and biological activity of the NGF solutions were confirmed using the morphological differentiation of PC12 cells in vitro (Buxser et al., 1983) . Working solutions were prepared at the time of surgery by dilution in Dulbecco's phosphate-buffered saline containing 0.1% rat serum albumin (purchased from Sigma Chemical Co., St. Louis), with the diluent also serving as the infusion vehicle. The concentration of NGF in the pump was adjusted for the flow rate of 2.5 pJhr so that the dose of NGF administered to the rat brain was 1.2 kg/d, a dose shown previously to maximally stimulate basal forebrain ChAT activity in axotomized young adult Sprague-Dawley female rats (Williams et al., 1989a) . Animals that were infused with vehicle solution with the albumin at 1 mg/ml added as a nonspecific protein served as controls.
Brain slice preparation. At the end of a 3 week infusion of NGF or vehicle, rats were sacrificed by decapitation and their brains quickly removed and placed in ice-cold-oxygenated artificial cerebrospinal fluih (ACSF). The comnosition of the ACSF (in mM) was: NaCl. 124: KCl. 3.5; &Cl,, 3.0; figSO,, 1.5; NaH,PO,,\ 1.0; NaHCO,, 26.2; glucose 11.0. Horizontal slices of ventral forebrain containing the amygdala were cut at a thickness of 500 pm using a Vibroslicer (World Precision Instruments). Slices were maintained in a holding chamber at room temperature submerged in ACSF that was continuously bubbled with 95% O,-5% CO,. Individual slices were transferred to the recording chamber as needed and held submerged between two layers of nylon mesh under continuously flowing ACSF, perfused at a rate of 1.0-1.5 ml/min and prewarmed to 32°C. Slices were allowed to equilibrate at least 1 hr before intracellular recordings were attempted. Intracellular recording. In the horizontal brain slice preparation used here, the BLA consists of a roughly triangular area that can be identified by its relationship to surrounding anatomical landmarks, being bordered laterally by the external capsule, caudomedially by the lateral ventricle and rostromedially by the stria terminalis. Neurons within this region were impaled with a single microelectrode pulled from 1.2 mm O.D. thin-walled glass capillary tubing. Current-clamp recordings were obtained with microelectrodes filled with 2 M potassium acetate (pH = 7.0) and having resistances of 90-120 MQ whereas those used for voltage-clamp recording had resistances of 30-100 MR and were filled with a solution of 2.7 M potassium chloride and 0.4 M potassium acetate. Intracellular discontinuous current current-clamp (DCC) and single-electrode voltage-clamp (SEVC) recordings were made using the Axoclamp 2A sample and hold amplifier (Axon Instruments, Foster City, CA) with a 30% dutv cvcle. as nreviouslv described Moises, 1992, 1993) . The sampling frequency in both modes was approximately 3.0 kHz. Amplified signals were displayed on a storage oscilloscope and outputted to a strip chart recorder, while a separate oscilloscope was used to continuously monitor the headstage output to verify that the voltage drop across the electrode had dissipated completely during the interval between current injection (30% of the cycle) and voltage sampling (70%). Voltage and current signals were also filtered at 300 Hz and fed to a computer interface (TL-100 interface, Axon Instruments) which digitized (at 0.3 kHz) the analog waveforms for storage and analysis off-line by a microcomputer-based program @CLAMP, Axon Instruments). In SEVC mode, gain settings of 3-8 nA/ mV produced clamp settling times of < 3 msec.
Only cells with membrane potentials more negative than -55 mV and overshooting action potentials were included in this study. Under our recording conditions, the vast majority of BLA neurons were not spontaneously active at the resting membrane potential, but could be made to fire by intracellular injection of depolarizing current through the recording electrode. Prolonged (250-350 msec) depolarizing current pulses (0.5-1.5 nA) were passed to cause neurons to discharge a short burst of action potentials, followed by a slow hyperpolarizing afterpotential that emerged upon termination of the depolarizing command, as previously described (Washburn and Moises, 1992a; Womble and Moises, 1993) . Input resistance was determined from current-voltage plots, constructed from the resultant voltage deflections produced by passage through the recording electrode of an incremental series of 150 msec current pulses (0.1 nA increments; range, -0.8 nA to + 1 .O nA). Membrane time constants were calculated for small hyperpolarizing current pulses (-0.3 to -0.2 nA) using a least-squares fit exponential-fitting program (CLAMPFIT, Axon Instruments). Activation of cholinergic ufjierents. Cholinergic inputs to BLA neurons were activated by delivering voltage pulses of 0.1 msec duration via a bipolar stimulating electrode placed on the surface of the slice over the nucleus basalis or the external capsule. Changes in the strength/ effectiveness of amygdalopetal cholinergic neurotransmission were assessed by comparing the ability of this electrical stimulation to elicit a slow muscarinic slow excitatory postsynaptic potential (slow EPSP) or inhibit the calcium-activated potassium slow afterhyperpolarization (slow AHP), as described in Washburn and Moises (1992a) in neurons in slices from control and NGF-treated rats. The cholinergic slow EPSP that is recorded in BLA pyramidal neurons results from the muscarinic blockade of both M-current, a voltage-dependent K+ conductance, and a second voltage-insensitive K' leak current (Womble and Moises, 1992) . For slow EPSP measurements neurons were held 8 mV negative to firing threshold with D.C. current and slow depolarizing responses recorded to a 500 msec tetanic stimulation of nucleus basalis or the external capsule through which the cholinergic projections travel to reach the BLA (Ichikawa and Hirata, 1986) . Manual clamping of the membrane potential -8 mV relative to spike threshold served to ensure that the test potential (-66 to -62 mV) from which these responses were elicited was within the mid-range for M-current activation such that a slow EPSP of at least 5 mV ampitude was obtained (see Washburn and Moises, 1992a; Womble and Moises, 1992) . For individual neurons, tetanic stimulation of the nucleus basalis or external capsule was first delivered at a constant frequency of 30 Hz and the stimulus strength adjusted in an incremental manner to establish an optimal range of stimulation intensity for generation of a cholinergic slow EPSP A series of responses was then evoked by delivering stimuli of a constant intensity at incrementing levels of stimulation frequency (lo-100 Hz) to characterize the stimulus frequency-response relationship. The constancy of stimulation current delivered over the course of the frequencyresponse analysis was routinely monitored by measurement of the voltage drop across a 10 MR precision resistor arranged in parallel with the stimulating electrode. When recording in the presence of eserine (see Results), threshold current intensity for eliciting a slow EPSP to a 500 ms, 30 Hz stimulation of the cholinergic fiber projections averaged 0.45 + 0.21 mA (0.3-0.75 mA. range for n = 15) in slices from NGFtreated rats, which was not significantly different from the mean of 0.53 t-0.28 mA (0.4-0.80 mA, range for n = 15) for control slices.
The same protocol was used with slight modification to quantitatively evaluate the inhibitory effect of cholinergic pathway stimulation on the slow AHP that followed a current-evoked burst of action potentials. For these experiments, sufficient current was passed through the recording electrode to hold the membrane potential constant at -60 mV and slow AHPs evoked at 15 set intervals by passage of an additional 200 msec pulse of depolarizing current. For each neuron, a series of slow AHP responses was collected prior to cholinergic pathway stimulation and following presentation of depolarizing test pulses that were preceded 3-5 set earlier by a 500 msec tetanic stimulation of nucleus basalis or the external capsule at a frequency of lo-100 Hz. Stimulus intensity was held constant throughout testing in a given neuron and was set to the level found to be optimal for elicitation of the slow cholinergic EPSP These conditions favored the elicitation of cholinergic synaptic inhibition of the slow AHP, given its much lower threshold for generation compared with that of the slow EPSP (Washburn and Moises, 1992) . In the event that cholinergic pathway stimulation produced a slow depolarization of the neuron, the membrane potential was reset to -60 mV at the time of elicitation of the current-evoked slow AHP to control for any voltage-dependent change in these responses.
Drug application. Drugs were dissolved in ACSF to their final concentration and applied to the slice by switching the bath superfusate from normal ACSF to drug containing medium via a multi-port valve system. In various experiments carbamyl chloride (carbachol), atropine sulfate, eserine or cadmium chloride (all obtained from Sigma Chemical) were added to the bathing medium. Some recordings were obtained in the presence of 1 FM tetrodotoxin (TTX, Sigma Chemical) to block action potential-dependent neurotransmitter release, thereby enabling us to confirm the synaptic nature of responses elicited by cholinergic pathway stimulation and to distinguish direct actions of drugs on the neuron under study from possible remote actions.
Data analysis. To construct the frequency-response relationship for elicitation of the cholinergic slow EPSP computerized averages were obtained of depolarizations evoked by three to five stimulation trials at a particular frequency and the peak amplitudes of the averaged responses expressed as absolute changes in millivolts relative to the prestimulation level of membrane potential. The amplitudes of these averaged responses were normalized to the maximal depolarization recorded in a given neuron and plotted as a function of the stimulation frequency to yield a complete frequency-response curve. To quantify the inhibitory effect of cholinergic pathway stimulation on the slow AHP, responses associated with each stimulus frequency were averaged over three trials and the areas of these averaged hyperpolarizing potentials (as measured below) compared against the value obtained for control responses in a given neuron, expressing effects as a % change ([Control -Test/Control] X 100). Cumulative stimulus frequency-response curves were derived by pooling results obta.ined from populations of neurons from control and NGF-treatment groups, and compared by determining the lowest stimulation frequency which produced a-halfmaximal deoolarizing resnonse (EF,,) or inhibition of the slow AHP (IF,,). The iesults obtained from N&treated rats were compared to those from controls using a two-way analysis of variance with repeated measures on one variable (frequency). Post-hoc analysis was done using the Dunnett test to compare the treatment group means to the control group means at each stimulation frequency. A single-blind protocol was followed when recordings were obtained from slices from NGF-treated and vehicle-treated animals with acquisition of data and subsequent analyses being performed without prior knowledge of the treatment regimen.
To quantify the inhibitory action of cholinomimetics on the slow AHP that follows a series of current-evoked action potentials, samples of four to eight digitized waveforms taken before, during drug application and after washout were averaged for each condition. From these averaged records, the area of the slow AHP was then calculated by integrating with respect to time the potential falling below baseline. The lower and upper time limits utilized for the integration of the slow AHP were the time following the current pulse when the slow hyperpolarizing potential first emerged from the decay phase of the preceding medium AHP and the time when the potential returned to the pre-pulse level, respectively. The concentration of drug required to inhibit the control AHP by 50% (EC,,) was calculated from the cumulative concentration-response curves generated for NGF-treated and control groups of neuron using linear regression analysis. All data are presented in the text as mean -C SEM.
Results
Effects of NGF on resting and active membrane properties The resting membrane properties of BLA pyramidal neurons recorded in slices from NGF-treated rats were not significantly different from those of control neurons, as shown in Table 1 . Data obtained in neurons from vehicle-treated animals (n = 16, 6 rats) and untreated controls (n = 29, 12 rats) have been pooled, since no apparent group differences were observed in either their passive or active membrane characteristics. Neurons studied after treatment with NGF (n = 40, 12 rats) were indistinguishable from controls in regard to their resting membrane potential (-69.5 2 0.7 mV for control, -68.5 2 0.7 mV for treated), input resistance (39.5 2 1.6 MR vs 41.2 + 1.9 Ma), time constant (15.7 2 0.7 msec vs 15.5 * 0.9 ms), action potential amplitude (93.0 + 2.0 mV vs 91.5 ? 2.7 mV) and spike duration (1.8 ? 0.1 msec vs 1.8 2 0.1 msec). The mean threshold for action potential generation also was not significantly different between control (-59.2 2 2.6 mV, n = 30) and NGF-treated neurons (-58.7 2 2.3 mV, n = 25). In most control and NGFtreated neurons, passage of a prolonged depolarizing current pulse (200-350 msec duration, 0.5-l .5 nA intensity) through the recording electrode evoked a burst of action potentials, followed by a medium and subsequent slow AHP (for example, see Fig.  4 ). The late slow hyperpolarizing potentials recorded in control neurons (n = 21) averaged 6.5 ? 2.4 mV in amplitude, had a mean duration of 3.6 + 0.8 set and wete blocked reversibly by bath application of cadmium (200 PM). The calcium-dependent slow AHPs recorded in neurons after NGF treatment showed very similar properties (amplitude of 6.0 + 0.5 mV and duration of 3.7 + 0.8 set, n = 16).
Responses to cholinergic pathway stimulation The effects of activation of cholinergic projections to the BLA were examined in 51 untreated control neurons following stimulation of nucleus basalis (n = 28) or the external capsule (n = 23). Repetitive stimulation of either site at 30 Hz for 500 msec (with 0.1 msec stimuli) elicited a series of short-latency fast EPSPs or action potentials followed by a hyperpolarization. We have shown previously that these fast depolarizing responses are noncholinergic in origin and are blocked by glutaminergic antagonists (Washburn and Moises, 1992, and unpublished observations) , whereas the hyperpolarizations result from activation of postsynaptic GABA, receptors (Washburn and Moises, 1992) . In recordings obtained in normal bathing medium, an atropinesensitive slow EPSP was seen to follow the hyperpolarizing response to nucleus basalis and external capsule stimulation in 8 of 28 (29%) and 12 of 23 (52%) neurons, respectively (Table  2 ). Bath application of the acetylcholinesterase inhibitor eserine (2 FM) increased the likelihood of evoking the slow cholinergic EPSP Thus, in the presence of eserine a muscarinic slow EPSP was observed in 8 of 9 neurons examined (4/5 from nucleus basalis, 4/4 from external capsule) in which tetanic stimulation had failed to evoke slow depolarizing responses in normal medium. These results suggest that the level of acetylcholinesterase activity in the slice is sufficiently high to modulate the efficacy of synaptic transmission within cholinergic projections from nucleus basalis to the BLA. We took advantage of this situation and routinely assessed the ability of cholinergic pathway stimulation to elicit a slow EPSP in control and NGF-treated slices during perfusion of normal bathing medium (containing no eserine) to better reveal a potential ability of NGF administration to enhance cholinergic neurotransmission. In all neurons the amplitude of the slow EPSP graded directly in relation to both the intensity and the number of stimuli used to activate cholinergic afferents within the slice. In the records shown in Figure 1A from an untreated control neuron, slow EPSPs were recorded with the cell held at a constant depolarized level (8 mV negative to threshold at -66 mV) while systematically varying the frequency of tetanic stimulation (0.1 msec pulses at 30 V intensity) delivered to the nucleus basalis. Whereas single stimuli rarely elicited a slow EPSP, even in the presence of eserine, responses to tetanic stimuli showed marked summation as the stimulation frequency was increased above 10 Hz Figure 1 . A, Chart records from a control BLA pyramidal neuron illustrate the effect of changing the frequency of tetanic stimulation of nucleus basalis on the cholinergic slow EPSP Tetanic stimulation consisted of a 500 msec train of pulses of 0.1 msec duration at 30 volts, delivered via a bipolar stimulating electrode placed on the surface of the slice. In this neuron stimulation of nucleus basalis at 10 Hz defined the threshold for elicitation of the slow EPSP with graded increases in EPSP amplitude and duration obtained as the stimulation frequency was increased up to 100 Hz. B, Chart records from a BLA neuron in an NGF-treated slice illustrate graded increases in amplitude and duration of a cholinergic slow EPSP elicited by 500 msec tetanic stimulation of nucleus basalis at increasing frequencies. In this neuron, the maxinal amplitude of the slow EPSP was produced by cholinergic pathway stimulation at 50 Hz and the slow synaptic response was abolished by perfusion of atropine 300 nM. Vertical bars at 10 msec in all traces are stimulus artifacts and small deflections in voltage records represent the occurrence of spontaneous synaptic potentials. Responses to cholinergic pathway stimulation were evoked from test potentials of -66 and -64 mV and resting membrane potentials were -74 mV and -73 mV, respectively, for the neurons in A and B.
and usually reached maximum amplitude at frequencies above 80 Hz. The amplitude of the slow EPSP in many neurons peaked at a level several mV positive to threshold. However, cholinergic pathway stimulation at the higher frequencies often resulted in the generation of a short burst of action potentials on the rising phase of the slow depolarizing potential (Fig. 1, record at 70 Hz). A 500 msec train of stimuli at 100 Hz served as the cutoff frequency for evaluation of all stimulus-response relationships, since stimulation at these parameters typically produced prolonged periods of intense discharge which precluded accurate measurement of the peak amplitude of the underlying slow depolarizing potential (see Fig. lA , record at 100 Hz). Figure 2 shows the frequency-response relationships for generation of the cholinergic slow EPSP by stimulation of nucleus A complete stimulus-response curve was generated for each neuron by evoking a series of slow EPSPs using 500 msec trains of lo-100 Hz stimuli, delivered'in an incremental progression of 10 Hz. The averaged responses elicited to three stimulus trials at each stimulation increment were normalized to the peak amplitude of the maximal depolarizing response for that neuron (it being designated as 100%) and the results for all neurons of a specified test group were then pooled and plotted as a function of stimulation frequency. Although external capsule stimulation was more efficacious than nucleus basalis stimulation in evoking slow EPSPs in control neurons (Table 2) , little difference was noted between the stimulus-response relationships for elicitation of cholinergic depolarizations produced by stimulation of these two sites. Comparison of the control curves generated for untreated neurons revealed that maximal effects were elicited with tetanic stimulation in the range of 90-100 Hz and yielded EFso values of 48 Hz and 42 Hz, respectively, for elicitation of slow cholinergic depolarizations to nucleus basalis and external capsule stimulation.
Effects of NGF treatment on amygdalopetal cholinergic transmission Treatment of rats intraventricularly with NGF for 3 weeks increased the likelihood of eliciting slow cholinergic EPSPs either by electrical stimulation of nucleus basalis or via activation of amygdalopetal projections that course within the external capsule. In brain slices that were obtained from the side ipsilateral to the NGF infusion and studied in normal bathing medium, stimulation of the nucleus basalis resulted in the generation of a slow atropine-sensitive EPSP in 12 of 18 (66.7%) neurons, whereas 12 of 15 (80%) neurons responded with a muscarinic slow depolarization to tetanic stimulation of the external capsule (Table 2 ). In addition, all but two of the 30 neurons examined in these slices responded with a muscarinic slow EPSP when cholinergic pathway stimulation was carried out in the presence of eserine (Table 2) . By contrast, a much lower proportion of neurons showed cholinergic responses to nucleus basalis (5 of 14 neurons, 35.7% in normal ACSF) or external capsule stimulation (9 of 16, 56.3% in normal ACSF) in slices prepared from the side of brain contralateral to the site of NGF infusion, mirroring the percentages of responsive neurons found in preparations from untreated controls (Table 2) . Nonetheless, administration of eserine (2 FM) resulted in the elicitation of cholinergic depolarizations in 6 of 8 neurons that failed to respond to nucleus basalis (2 of 4) or external capsule stimulation (4 of 4) when recordings were obtained from contralateral side slices during perfusion of control medium. It should be noted that the peak amplitudes of the slow EPSPs, when elicited from test potentials 8 mV negative to threshold, were not significantly different between control (10.8 i-2.1 mV for nucleus basalis, 11.6 i 1.3 for external capsule) and NGF-treated neurons located either ipsilateral (1 1.7 + 2.1 mV and 12.1 + 1.9 mV) or contralateral to the site of infusion (11.4 -t 2.3 mV and 10.9 ? 2.5 mV). The slow EPSPs in neurons from NGF-treated rats (n = 10 examined from the ipsilateral side) also closely resembled those recorded in controls with regard to their voltage dependence (E,,, = -71.5 ? 2.8 mV compared to -72.5 i-3.1 mV for controls, n = 12) and sensitivity to blockade by atropine (0.3-l pM being sufficient to eliminate responses to nucelus To quantitatively evaluate this apparent facilitating effect of NGF treatment on cholinergic transmission from the nucleus basalis to the BLA, we compared the stimulus-response relationships for generation of the slow EPSP in neurons from control and NGF-treated slices. Chronic treatment with NGF resulted in a twofold parallel shift to the left in the frequencyresponse curve for the nucleus basalis-induced slow EPSP ( Fig.   2A ) with a significant group effect (F,,,, = 14.06, p < 0.005, repeated measures ANOVA). The frequency of nucleus basalis stimulation required to elicit a half-maximal response (EF,,) was reduced significantly from 47 2 5 Hz in untreated control neurons to 30 i-5 Hz in neurons studied after treatment with NGF 0, < 0.01, Fig. 2A ). In addition, the amplitudes of the depolarizations elicited by stimulation at frequencies between 10 and 60 Hz (when normalized to the maximal response for a given neuron) were significantly greater in neurons studied in NGFtreated preparations compared to controls. Treatment of rats with NGF also produced a leftward shift in the frequency-response curve (1.5fold at EFsO, F,,,, = 8.125, p < 0.05) and significantly reduced the EF,, (from 43 2 4 Hz in untreated controls to 2X + 5 Hz, p < 0.05) for elicitation of the slow EPSP by external capsule stimulation (Fig. 2B) .
The ability of NGF treatment to enhance amygdalopetal cholinergic transmission was evident as well when comparisons were made between neurons in slices from NGF-treated animals and preparations obtained from vehicle-treated controls (Fig. 3 ). For these analyses the data derived from nucleus basalis and external stimulation were pooled to obtain sufficient numbers of responsive neurons in control preparations (4/14 to basalis and 7/15 for capsule stimulation) for construction of frequency-response curves. Visual inspection of the curves depicted in Figure  3 revealed that the EF,, for evoking cholinergic responses was significantly reduced in neurons from NGF-treated slices compared to those obtained from vehicle-treated controls (30 ? 4 Hz versus 48 ? 7 Hz, p < 0.01) with significant effects of NGF found at stimulation frequencies ranging from 10 to 60 Hz (Fig.  3) . From these data we concluded that the facilitation of cholinergic transmission observed in slices from NGF-treated rats did not arise as a consequence of cannula implantation or brain infusion, but rather most likely reflected a specific effect of NGF administration.
A second electrophysiological endpoint of cholinergic synaptic action that can be elicited in BLA pyramidal neurons by activation of inputs from nucleus basalis is blockade of the slow AHP that follows a burst of action potentials (Washburn and Moises, 1992; Womble and Moises, 1993) . These response measurements were obtained concurrently with evaluations of frequency-response relationships for the cholinergic slow EPSP so as to ascertain the reliability of the latter analyses in documenting a facilitation of cholinergic transmission by NGE With the maximal response to cholinergic pathway stimulation established as 100% inhibition of the slow AHP for a given neuron, frequency-inhibition curves generated for treatment and control groups could be compared without use of normalized data. The ability of nucleus basalis or external capsule stimulation to inhibit the current-evoked slow AHP was examined in 13 of 20 untreated control and 15 of 24 NGF-treated neurons in which slow cholinergic depolarizations were elicited. As shown by the family of voltage traces in Figure 4A from a control neuron, activation of cholinergic afferents to the BLA via 500 msec tetanic stimulation at either site in the slice produced graded reductions in the current-evoked slow AHP which varied in relation to the stimulus frequency. Stimulation of cholinergic input to the BLA appeared to be equally efficacious in producing suppression of the slow AHP among neurons in control and NGFtreated preparations, yielding averaged maximal inhibitions of 83 -C 8% and 90 -C 6% of the control response, respectively (Fig. 4B) . In contrast, chronic treatment with NGF shifted the frequency-response curve for inhibition of the slow AHP 16 fold to the left (compared at EF,, level of 26 -C 7 Hz versus 41 ? 4 Hz for controls), with significant between group effects of NGF observed at lower stimulation frequencies of 20-40 Hz (p < 0.05, Fig. 4B ).
Locus of NGF-induced enhancement in cholinergic transmission
As noted in the introductory section, the stimulatory effects of NGF on cholinergic neuron function have been shown to result in an augmented release of endogenous ACh elicited by depolarization of cholinergic nerve terminals in brain slice preparations of frontal cortex, hippocampus, or striatum . A similar presynaptic mechanism might underlie the enhanced responsiveness of BLA pyramidal neurons to cholinergic pathway stimulation observed here after treatment with NGF. Alternatively, prolonged administration of NGF could have additional effects, possibly independent of those on cholinergic neurons, which serve to increase postsynaptic responsiveness of BLA neurons to cholinergic input from nucleus basalis. To distinguish between these two possibilities we compared the inhibitory effects of bath application of carbachol on the calciumactivated slow AHP that follows a current-evoked burst of action potentials in pyramidal neurons from control and NGF-treated animals (see Fig. 5A ). These experiments were carried out in the presence of TTX (1 PM) to ensure that the effects of the agonist reflected a direct action 'on the neuron under study. The slow AHPs recorded in NGF-treated neurons (n = 9) were essentially indistinguishable from those in controls (untreated, IZ = 4; vehicle-treated, n = 5) (Table l) , and the responses in all neurons were reduced by carbachol in a reversible and concentration-dependent manner. Treatment of rats with NGF for 3 weeks did not affect the concentration-response curve for carbachol-induced inhibition of the slow AHP (Fig. 5B) . Although the maximal inhibitory effect of the agonist was obtained at a slightly lower concentration in NGF-treated neurons (3 FM), compared to controls (10 PM), there was no significant difference in the EC,, values between the two groups (0.50 pM for controls, 0.47 FM for NGF-treated). Similarly, measurements taken under voltage clamp revealed that administration of 3 pM carbachol produced comparable (greater than 90%) suppression of the underlying Z,,, current in control (n = 3) and NGF-treated neurons (n = 2) (Fig. 5A, bottom panel) . In current clamp recordings, the carbachol-induced blockade of the slow AHP was sometimes accompanied by a slow cholinergic depolarization, particularly during administration of higher concentrations of agonist. While not systemically examined, the concentration-response relationship for this effect of carbachol did not appear to be different for NGF-treated (n = 3) versus control (n = 4) neurons, with 300 nM and 10 PM of the agonist defining threshold and maxiamlly effective concentrations, respectively, in both groups (data not shown).
Discussion
The major new finding of this study is that chronic i.c.v. administration of NGF in normal adult rats enhances cholinergic neurotransmission between the nucleus basalis and BLA pyramidal neurons. The enhancement in cholinergic synaptic efficacy that accompanies NGF treatment was manifested here by (1) a marked increase in the probability of eliciting slow muscarinic EPSPs in response to stimulation of nucleus basalis or cholinergic fibers within the external capsule, (2) a twofold leftward shift in the frequency-response relationship for generation of these depolarizing responses, and (3) a significant reduction in the EF,,, for blockade of the slow AHP in pyramidal neurons via cholinergic pathway stimulation. Gahwiler and coworkers (Gahwiler et al., 1987) previously reported that administration of NGF to cocultures of septal and hippocampal slices from neonatal rats greatly increased the ingrowth of cholinergic fibers that invaded the hippocampus and that these morphological effects were accompanied by an enhanced synaptic activity monitored by electrophysiological recording from hippocampal pyramidal neurons. In addition, Tuszynski et al. (Tuszynski et al., 1990) were able to restore a cholinergic component of behavioral-dependent hippocampal theta activity following complete interruption of the septo-hippocampal pathway in rats by a combination of intracerebral grafting of fetal hippocampal tissue into the lesion cavity and i.c.v. infusion of NGE The present data extend these findings by demonstrating that administration of exogenous NGF is capable of modulating the effectiveness of cholinergic transmission not only during development or following damage to axonal pathways but also within intact cholinergic projections of nucleus basalis in normal adult brain. Several lines of evidence suggest that the enhancement in choalterations in cholinergic synaptic function can be presumed to linergic transmission between nucleus basalis and BLA resulted reflect a specific effect of NGF, since chronic i.c.v. administrafrom a specific trophic action of NGF exerted on the presynaptic tion of the vehicle plus albumin as a control protein did not cholinergic neurons. First, treatment of rats with NGF for 3 facilitate transmission between nucleus basalis and the BLA. In weeks did not alter the resting or active membrane properties of addition, no significant changes were observed in the ef'fective-BLA pyramidal neurons, nor did it affect their intrinsic excitness of cholinergic transmission between nucleus basalis and the ability. Second, the sensitivity and responsiveness of' pyramidal BLA in brain slices from NGF-treated animals that were obneurons to direct application of the muscarinic receptor agonist tained from the side opposite the infusion. Lastly, the facilitation carbachol were unchanged after NGF treatment. Hence, the enoF cholinergic amygdalopetal transmission induced by NGF hancement in cholinergic synaptic transmission found after NGF treatment was most prominently expressed when the effects of must occur independent of alterations in postsynaptic mechacholinergic pathway stimulation were compared in control and nisms involved in the reception or transduction of the muscarinic NGF-treated slices during superfusion with normal bathing mesignal. In keeping with this are the findings from radioligand dium. By contrast, no significant difference in responsiveness to experiments that NGF treatment in normal adult rats or those cholinergic pathway stimulation was observed between NGFwith partial transections of the hmbria/fornix does not alter MI treated neurons and controls when results from treated animals or M2 muxcarinic receptor densities in hippocampus (Araujo et were compared against data obtained from control slices during al., 1993; Lapchak et al., 1993) . Thus, it seems likely that the blockade of AChE activity with eserine. The latter result supincreased responsiveness to cholinergic pathway stimulation ports the hypothesis that the increased efficacy of cholinergic found in forebrain slices from NGF-treated rats reflected changes transmission found after treatment with NGF derived at least in occurring presynaptically to the neuron under study. Third, such part from a facilitation of impulse-dependent release of ACh. Recent studies indicate that in addition to its prominent cholinergic input from basal forebrain, the amygdala in rat receives innervation from a second, newly identified population of NGFresponsive neurons in the paraventricular anterior and reuniens nuclei, located within the thalamic medline (Holtzman et al., 1995; Venero et al., 1995) . The neurons in these nuclei that demonstrate trkA mRNA expression are noncholinergic, yet they undergo hypertrophy in response to chronic intraventricular infusion of NGF (Venero et al., 1995) as do the ChAT-positive neurons in nucleus basalis . Although indirect evidence suggests that the projections from these midline thalamic nuclei may exert an excitatory influence on their amygdaloid targets, we lack sufficient information to predict how NGF-related effects within this neuronal system might influence any of the electrophysiological measurements taken here. Notwithstanding this, the fact that the properties of BLA pyramidal neurons were unaltered after NGF treatment supports the conclusion that altered functioning of this thalamo-amygdaloid projection did not contribute to the observed enhancement in cholinergic neurotransmission between the nucleus basalis and the BLA.
The NGF-induced enhancement of amygdalopetal cholinergic transmission was observed irrespective of whether cholinergic responses in BLA neurons were elicited by electrical stimulation of nucleus basalis or activation of cholinergic fibers within the external capsule. This suggests that the facilitation in cholinergic signaling between nucleus basalis neurons and BLA pyramidal cells resulted from alterations in synaptically related processes, rather than changes affecting cholinergic somatic function. In addition, the observed effects were unlikely to be related to an increased excitability of the cholinergic fibers to electrical stimulation, since the current level that defined threshold stimulation for eliciting cholinergic responses in slices from NGF-treated animals was not significantly different from that for controls. Chronic administration of NGF has been shown to stimulate the expression of cholinergic biosynthetic ~enzymes in basal forebrain neurons of normal adult and aged rats, increasing the activity of ChAT and producing neuronal hypertrophy within the nucleus basalis and medial septum/diagonal band Williams et al., 1989b) , while enhancing the activities of ChAT and HACU in forebrain target areas (Williams and Rylett, 1990; Williams, 199 1; Rylett et al., 1993) . We reported in frontal cortex and hippocampus of young adult rats that NGF-induced stimulations of ChAT and choline uptake activities were accompanied by an enhanced synaptosomal synthesis of 'H-ACh (from 'H-choline) and increases in basal and depolarization-evoked release of both endogenous and newly synthesized transmitter, measured in vitro from synaptosomal and brain slice preparations . In addition, regression analysis revealed that the magnitude of the NGF-induced increase in depolarization-evoked 'H-ACh release from cholinergic nerve terminals in cortical or hippocampal slices was highly correlated with the increase in ACh synthesis in both areas . A similar relationship might exist for cholinergic projections to the amygdala and account for the NGF-induced enhancement in cholinergic transmission via impulse-dependent release of endogenous ACh found here. In support of this hypothesis is the demonstration from earlier anatomical work in rat that a small subpopulation of nucleus basalis neurons that project to cortex in rat also provide cholinergic innervation to the BLA (Carlsen et al., 1985) . Nevertheless, other studies performed in aged Fishcer 344 rats (Mervis et al., 1991) or in adult animals with unilateral devascularizing cortical lesions have demonstrated that infusion of NGF (Garofalo et al., 1992; Cue110 et al., 1993) or implantation of NGF-producing transfected cells (Ernfors et al., 1989) can profoundly effect the cholinergic presynaptic terminal network, eliciting hypertrophy of cortical cholinergic terminals and a remodeling of their synaptic relationships. Conceivably, the net effect of either a proliferation of additional cholinergic synapses or rearrangement of the points of synaptic contact to more strategic loci along the somato-dendritic tree would result in an increased ability of presynaptic cholinergic afferent activity to influence postsynaptic receiving neurons. In future work, it will be necessary to pursue ultrastructural analyses at the EM level in combination with immunostaining for ChAT-positive terminals and varicosities to assess the possibility that the facilitating effect of NGF on cholinergic transmission to the BLA might reflect such a reorganization of the synaptic relationship between cholinergic nerve terminals and their neuronal target cells.
A major contention of this report is that the monosynaptic projection of cholinergic afferents from nucleus basalis to BLA pyramidal neurons provides a useful experimental model to examine the ability of exogenous NGF to promote functional plasticity of forebrain cholinergic projection systems in adult and aged animals. The search for such models has been prompted by an awareness that geriatric cognitive impairment, and Alzheimer's disease in particular, are characterized by dysfunction and loss of basal forebrain cholinergic neurons, and by a growing body of experimental data which suggests that treatment with exogenous NGF might limit the extent of this cholinergic neurodegeneration. Study of the cholinergic projection from nucleus basalis to BLA has relevance from a clinical perspective, given that post-mortem neuropathological examinations of human brain have demonstrated a severe and regionally selective loss of cholinergic innervation of the amygdaloid complex in AD (Sarter and Markowitsch, 1985a; Emre et al., 1993) . In addition, experimental studies in rats have shown that disruption of cholinergic amygdalopetal projections from nucleus basalis produces behavioral impairment in a variety of memory tasks (Beninger et al., 1994) , as does electrolytic lesioning of the BLA (Sarter and Markowitsch, 1985b) . The postsynaptic effects arising from activation of nucleus basalis cholinergic input to the BLA in rat have now been wellcharacterized by intracellular recording (Washburn and Moises, 1992a; Moises, 1992, 1993) , and the anatomical features of these amygdalopetal projections have been resolved in detail at both the light microscopic and ultrastructural level (Woolf and Butcher, 1982; Mesulam et al., 1983; Carlsen et al., 1985; Hellendall et al., 1986) . Moreover, cholinoresponsive neurons within the amygdala appear to be an important source of target-derived NGE Gall and Isackson (Gall and Isackson, 1989) , using in situ hybridization analyses for NGF mRNA, detected moderately dense labeling of neurons throughout the amygdaloid complex in rat. These investigators also found that limbic seizures markedly increased the amygdaloid expression of mRNA for NGF, raising the possibility of a dynamic and activity-dependent regulation of neurotrophic factor production. Nevertheless, uncertainty persists regarding the extent to which target-derived NGF exerts a physiological influence on the specific population of cholinergic neurons that provide innervation to the BLA. Thus, immunohistochemical studies with monoclonal antibodies raised against the low affinity (~75) NGF receptor (NGFr) have revealed only a sparse density of NGFr-positive fibers and terminals in rat and primate BLA nucleus (Kordower et al., 1988; Pioro and Cuello, 1990; Heckers and Mesulam, 1994) . Recently, Heckers and Mesulam (Heckers and Mesulam, 1994) showed further in Sprague-Dawley rats that the cholinergic innervation of the BLA remained essentially intact following a complete loss of NGFr-positive neurons in basal forebrain induced by injections of 192 IgG-saporin. The apparent discrepancy between these anatomical observations and the experimental outcome described here might be reconciled based on differences in strains of rodents used, particularly since forebrain cholinergic neurons in the Fischer 344 rat exhibit much greater sensitivity and responsiveness to stimulation by exogenous NGF than do those in Spargue-Dawley rats (Decker, 1987; Williams, 199 1) . Alternatively, the enhancement in cholinergic transmission between nucleus basalis and BLA that resulted from exogenous NGF administration could reflect an action on cholinergic neurons independent of that normally mediated by the target-derived neurotrophic factor. In this regard, chronic infusion of NGF into adult rat brain has been shown to induce NGFr gene expression in nucleus basalis and result in reexpression in striatal cholinergic neurons of NGF receptors which are lost during postnatal development . Such a mechanism might act to enhance the responsiveness to exogenously administered NGF, and thereby augment transmitter related functions, among cholinergic amygdalopetal projection neurons, irrespective of their normal NGFr innervation density. In any event, the present results are significant in demonstrating that chronic infusion of NGF can facilitate the transmission of cholinergic signals between nucleus basalis neurons and their postsynaptic target cells in adult brain, yielding an effect that is likely to have physiological relevance for mnemonic processing within the BLA.
